The aberrant expression of the EGFR via gene amplification, mutation, or the overexpression of protein results in tumorigenesis, due to dysregulation of the EGFR-mediated signaling pathways, especially in lung cancer 39, 40. This evidence concerns the gene EGFR and lung carcinoma.